SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 12th, 2017 • Intellipharmaceutics International Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of October 11, 2017, between Intellipharmaceutics International Inc., a company organized under the laws of Canada (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
STRICTLY CONFIDENTIAL Intellipharmaceutics International Inc.Exclusive Agency Agreement • October 12th, 2017 • Intellipharmaceutics International Inc. • Pharmaceutical preparations • New York
COMMON STOCK PURCHASE WARRANT INTELLIPHARMACEUTICS INTERNATIONAL INC.Common Stock Agreement • October 12th, 2017 • Intellipharmaceutics International Inc. • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [________], 2018 [six months after the date hereof] (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on [________] (the “Termination Date) but not thereafter, to subscribe for and purchase from Intellipharmaceutics International Inc., a company organized under the laws of Canada (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is one of the Common Stock Purchase Warrants (the "Warrants") issued pursuant to that certain Engagement Agreement, by and between the Company and H.C. Wainwright
